Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, July 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 174 articles:
HTML format


 

Single Articles

  1. NATHAN SD, Waxman A, Rajagopal S, Case A, et al
    Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.
    Lancet Respir Med. 2021 Jun 29. pii: S2213-2600(21)00165.
    PubMed    
    Abstract available

  2. SAMANT S, Tran HV, Uddo RB, deBoisblanc BP, et al
    Use of Handheld Ultrasound to Estimate Right Atrial Pressure in a Pulmonary Hypertension Clinic.
    Ann Am Thorac Soc. 2021 Jul 2. doi: 10.1513/AnnalsATS.202101.
    PubMed    
    Abstract available

  3. TANGMAHAKUL N, Makoom P, Surachetpong SD
    Assessment of Platelet and Plasma Serotonin in Canine Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease.
    Front Vet Sci. 2021;8:695492.
    PubMed    
    Abstract available

  4. MENON DP, Qi G, Kim SK, Moss ME, et al
    Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211025240.
    PubMed    
    Abstract available

  5. MONTAGNOLI TL, da Silva JS, Sudo SZ, Santos AD, et al
    ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.
    Cells. 2021;10.
    PubMed    
    Abstract available

  6. TORBICKI A
    Pulmonary Hypertension: Diagnosis and Management.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  7. BAZ L, Rossberg M, Grun K, Kretzschmar D, et al
    Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A(+) Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  8. GIUCA A, Mihai C, Jurcut C, Gheorghiu AM, et al
    Screening for Pulmonary Hypertension in Systemic Sclerosis-A Primer for Cardio-Rheumatology Clinics.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  9. HAUTBERGUE T, Antigny F, Boet A, Haddad F, et al
    Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure.
    Cells. 2021;10.
    PubMed    
    Abstract available

  10. ROUBENNE L, Marthan R, Le Grand B, Guibert C, et al
    Hydrogen Sulfide Metabolism and Pulmonary Hypertension.
    Cells. 2021;10.
    PubMed    
    Abstract available

  11. TANG SY, Ma HP, Hung CS, Kuo PH, et al
    The Value of Heart Rhythm Complexity in Identifying High-Risk Pulmonary Hypertension Patients.
    Entropy (Basel). 2021;23.
    PubMed    
    Abstract available

  12. TAKEUCHI H, Achiwa I, Takei T, Kondo R, et al
    [Pulmonary Artery Replacement in a Patient with Pulmonary Artery Dissection Associated with Pulmonary Hypertension and Single Ventricle:Report of a Case].
    Kyobu Geka. 2021;74:539-542.
    PubMed    
    Abstract available

  13. KATRIEN M, Dieter S, Anke D, Amelie D, et al
    Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.
    Acta Clin Belg. 2021 Jun 30:1-6. doi: 10.1080/17843286.2021.1945352.
    PubMed    
    Abstract available

  14. LV ZC, Li F, Wang L, Zhao QH, et al
    Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension.
    Am J Mens Health. 2021;15:15579883211029458.
    PubMed    
    Abstract available

  15. MUKHERJEE D, Konduri GG
    Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.
    Compr Physiol. 2021;11:2135-2190.
    PubMed    
    Abstract available

  16. BOURNIA VK, Kallianos A, Panopoulos S, Gialafos E, et al
    Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study.
    Rheumatol Int. 2021 Jun 29. pii: 10.1007/s00296-021-04937.
    PubMed    
    Abstract available

  17. RASHIDI F, Mousavi-Aghdas SA, Kaymaz C
    Is the maternal risk of pregnancy acceptable in patients with moderate pulmonary hypertension?
    Pulm Circ. 2021;11:20458940211023697.
    PubMed    


  18. SANGANI R, Ghio A, Culp S, Patel Z, et al
    Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.
    Int J Chron Obstruct Pulmon Dis. 2021;16:1873-1885.
    PubMed    
    Abstract available

  19. SHARMA M, Rana U, Joshi C, Michalkiewicz T, et al
    Decreased Cyclic GMP-protein Kinase G signaling impairs Angiogenesis in a Lamb Model of Persistent Pulmonary Hypertension of Newborn.
    Am J Respir Cell Mol Biol. 2021 Jun 29. doi: 10.1165/rcmb.2020-0434.
    PubMed    
    Abstract available

  20. CURRIE B, Davies E, Beaudet A, Stassek L, et al
    Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study.
    J Patient Rep Outcomes. 2021;5:51.
    PubMed    
    Abstract available

  21. JENEI C, Kadar R, Balogh L, Borbely A, et al
    Role of 3D echocardiography-determined atrial volumes in distinguishing between pre-capillary and post-capillary pulmonary hypertension.
    ESC Heart Fail. 2021 Jun 28. doi: 10.1002/ehf2.13496.
    PubMed    
    Abstract available

  22. KAGAMI K, Harada T, Yamaguchi K, Kouno S, et al
    Association between lung ultrasound B-lines and exercise-induced pulmonary hypertension in patients with connective tissue disease.
    Echocardiography. 2021 Jun 29. doi: 10.1111/echo.15141.
    PubMed    
    Abstract available

  23. MEMIC SANCAR K, Topel C, Turen S, Erturk M, et al
    An overlooked cause for reversible severe tricuspid regurgitation and pulmonary hypertension: Hibernating right ventricle.
    Echocardiography. 2021 Jun 29. doi: 10.1111/echo.15138.
    PubMed    
    Abstract available

  24. CALE R, Ferreira F, Pereira AR, Repolho D, et al
    Safety and efficacy of balloon pulmonary angioplasty in a Portuguese pulmonary hypertension expert center.
    Rev Port Cardiol. 2021 Jun 25. pii: S0870-2551(21)00194.
    PubMed    
    Abstract available

  25. MADONNA R, Fabiani S, Morganti R, Forniti A, et al
    Exercise-induced pulmonary hypertension in HIV patients: Association with poorer clinical and immunological status.
    Vascul Pharmacol. 2021 Jun 25:106888. doi: 10.1016/j.vph.2021.106888.
    PubMed    
    Abstract available

  26. ADAIR JD, Kelly B, Schilling D, Parkhotyuk K, et al
    Pulmonary Function Tests in Very Low Birth Weight Infants Screened for Pulmonary Hypertension: A Pilot Study.
    J Pediatr. 2021 Jun 25. pii: S0022-3476(21)00628.
    PubMed    
    Abstract available

  27. ZENG X, Huang X, Rathinasabapathy A, Xu Z, et al
    Prevalence of Schistosoma japonicum-associated Pulmonary Hypertension in China: An Echocardiography-based Assessment.
    Ann Am Thorac Soc. 2021 Jun 28. doi: 10.1513/AnnalsATS.202012-1573.
    PubMed    


  28. SITAPARA R, Sugarragchaa C, Zisman LS
    SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling.
    Pulm Circ. 2021;11:20458940211021528.
    PubMed    
    Abstract available

  29. RAVI Y, Sai-Sudhakar CB, Kuppusamy P
    PTEN as a Therapeutic Target in Pulmonary Hypertension Secondary to Left-heart Failure: Effect of HO-3867 and Supplemental Oxygenation.
    Cell Biochem Biophys. 2021 Jun 16. pii: 10.1007/s12013-021-01010.
    PubMed    
    Abstract available

  30. ESNAUD R, Gagnadoux F, Beurnier A, Berrehare A, et al
    The association between sleep-related breathing disorders and pre-capillary pulmonary hypertension: A chicken and egg question.
    Respir Med Res. 2021;80:100835.
    PubMed    
    Abstract available

  31. SHARMA S, Stansbury R, Hackett B, Fox H, et al
    Sleep apnea and pulmonary hypertension: A riddle waiting to be solved.
    Pharmacol Ther. 2021;227:107935.
    PubMed    
    Abstract available

  32. WANG J, Li H, Xia T, Feng J, et al
    Pulmonary arterial hypertension and flavonoids: A role in treatment.
    Chin J Physiol. 2021;64:115-124.
    PubMed    
    Abstract available

  33. ZHAO Q, Song P, Zou MH
    AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling.
    Front Cell Dev Biol. 2021;9:691585.
    PubMed    
    Abstract available

  34. MAHMOOD UF, Durairaj S
    Patent ductus arteriosus-related endocarditis: not just a theoretical risk.
    BMJ Case Rep. 2021;14.
    PubMed    


  35. FARIAS LPG, Favaretto AC, Baptista LPS, Teles GBDS, et al
    Pulmonary Arterial Intramural Hematoma Due to Acute Aortic Dissection.
    Arq Bras Cardiol. 2021;116:1169-1171.
    PubMed    


  36. WEST JD, Austin ED, Rizzi EM, Yan L, et al
    KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  37. GIANNI S, Carroll RW, Kacmarek RM, Berra L, et al
    Inhaled Nitric Oxide Delivery Systems for Mechanically Ventilated and Nonintubated Patients: A Review.
    Respir Care. 2021;66:1021-1028.
    PubMed    
    Abstract available

  38. KOORANIFAR S, Naghshin R, Sezavar SH, Hajsadeghi S, et al
    Diagnostic value of chest spiral CT scan and Doppler echocardiography compared to right heart catheterization to predict pulmonary arterial hypertension in patients with scleroderma.
    Acta Biomed. 2021;92:e2021074.
    PubMed    
    Abstract available

  39. ARVIDSSON M, Ahmed A, Bouzina H, Radegran G, et al
    Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension.
    ESC Heart Fail. 2021;8:1230-1243.
    PubMed    
    Abstract available

  40. BOUZINA H, Radegran G, Butler O, Hesselstrand R, et al
    Longitudinal changes in risk status in pulmonary arterial hypertension.
    ESC Heart Fail. 2021;8:680-690.
    PubMed    
    Abstract available

  41. KOUBSKY K, Tlaskal T, Chaloupecky V, Janousek J, et al
    How many types of circulation can a boy have during his life? A case of aortic stenosis with a borderline left ventricle.
    ESC Heart Fail. 2021;8:774-777.
    PubMed    
    Abstract available

  42. CAPEL A, Levy M, Szezepanski I, Malekzadeh-Milani S, et al
    Potts anastomosis in children with severe pulmonary arterial hypertension and atrial septal defect.
    ESC Heart Fail. 2021;8:326-332.
    PubMed    
    Abstract available

  43. GIGANTE A, Villa A, Rosato E
    Laser speckle contrast analysis predicts major vascular complications and mortality of patients with systemic sclerosis.
    Rheumatology (Oxford). 2021;60:1850-1857.
    PubMed    
    Abstract available

  44. KAMIDE H, Kato S, Hayakawa K, Fukui K, et al
    Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.
    Int J Cardiovasc Imaging. 2021;37:1073-1083.
    PubMed    
    Abstract available

  45. SEAMAN CS, d'Udekem Y, Jones BO, Brizard CPR, et al
    Augmentation of Pulmonary Arterial Growth in Single Ventricle Patients by Interim Selective Shunts.
    Semin Thorac Cardiovasc Surg. 2021;33:483-489.
    PubMed    
    Abstract available

  46. MALINAUSKIENE L, Slekyte G, Mowitz M, Isaksson M, et al
    Allergic contact dermatitis caused by isobornyl acrylate in two patients treated for idiopathic pulmonary arterial hypertension.
    Contact Dermatitis. 2020 May 20. doi: 10.1111/cod.13617.
    PubMed    


  47. HABIB P, Podgorski M, Adorini K, Brown M, et al
    First Reported Case of Pulmonary Arterial Hypertension Secondary to Tofacitinib Treatment for Undifferentiated Arthritis.
    J Clin Rheumatol. 2021;27:e136-e138.
    PubMed    



  48. Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2021;18:1266.
    PubMed    


  49. DAHIM M, Mitha M, Connolly C, Nyamande K, et al
    Pulmonary hypertension: Spectrum of disease, clinical presentation and treatment outcomes at the main respiratory pulmonary hypertension clinic in KwaZulu-Natal Province, South Africa.
    Afr J Thorac Crit Care Med. 2021;27.
    PubMed    
    Abstract available

  50. RAINE R
    More welcome data on pulmonary hypertension in South Africa.
    Afr J Thorac Crit Care Med. 2021;27.
    PubMed    


  51. FLACHSKAMPF FA
    Right Ventricular Strain in Pulmonary Hypertension: Looking at the Small Print.
    JACC Cardiovasc Imaging. 2021;14:1487-1488.
    PubMed    


  52. POLAK M, Grabka M, Wrobel W, Wozniak-Skowerska I, et al
    When Takayasu mimics pulmonary hypertension -severe pulmonary artery stenosis - what to do?
    Kardiol Pol. 2021 Jul 8. pii: VM/OJS/J/84634. doi: 10.33963/KP.a2021.0059.
    PubMed    


  53. OBIKANE H, Kaneko M, Kasao M, Kumagai H, et al
    Chronic Thromboembolic Pulmonary Hypertension Complicated by Giant Pulmonary Artery Aneurysm.
    Int Heart J. 2021 Jul 6. doi: 10.1536.
    PubMed    
    Abstract available

  54. SUGIMOTO K, Yokokawa T, Misaka T, Kaneshiro T, et al
    High-fat diet attenuates the improvement of hypoxia-induced pulmonary hypertension in mice during reoxygenation.
    BMC Cardiovasc Disord. 2021;21:331.
    PubMed    
    Abstract available

  55. MULAREK-KUBZDELA T, Ciurzynski M, Kowal Bielecka O, Kasprzak JD, et al
    An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation and the Polish Society for Rheumatology on the diagnosis and treatment of pulmonary hypertension in patients with connective tissue disease.
    Kardiol Pol. 2021 Jul 6. pii: VM/OJS/J/84480. doi: 10.33963/KP.a2021.0055.
    PubMed    
    Abstract available

  56. SONG L, Quan ZL, Zhao LY, Cui DM, et al
    Impact of pulmonary hypertension on arteriovenous fistula failure of hemodialysis patients: A 10 years follow-up cohort study.
    J Vasc Access. 2021 Jul 6:11297298211027408. doi: 10.1177/11297298211027408.
    PubMed    
    Abstract available

  57. BAHADORAN S, Hassanpour H, Arab S, Abbasnia S, et al
    Changes in the expression of cardiac genes responsive to thyroid hormones in the chickens with cold-induced pulmonary hypertension.
    Poult Sci. 2021;100:101263.
    PubMed    
    Abstract available

  58. ZHAO QH, Wu WH, Fu LJ, Wang L, et al
    Adult-onset hypoxaemia, diffuse lung lesions, and pulmonary hypertension in cobalamin C defect: a case report.
    Eur Heart J Case Rep. 2021;5:ytab251.
    PubMed    
    Abstract available

  59. TADIC M, Nita N, Schneider L, Kersten J, et al
    The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases.
    Front Cardiovasc Med. 2021;8:698158.
    PubMed    
    Abstract available

  60. ZHAO YL, Yuan P, Zhao QH, Gong SG, et al
    Comparative Effectiveness of Exercise Training for Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy: A Systematic Review and Meta-Analysis.
    Front Cardiovasc Med. 2021;8:664984.
    PubMed    
    Abstract available

  61. ZHOU B, Zhu YJ, Zhai ZQ, Weng SX, et al
    Radiofrequency Catheter Ablation of Supraventricular Tachycardia in Patients With Pulmonary Hypertension: Feasibility and Long-Term Outcome.
    Front Physiol. 2021;12:674909.
    PubMed    
    Abstract available

  62. DAROCHA S, Roik M, Kopec G, Araszkiewicz A, et al
    Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Registry.
    EuroIntervention. 2021 Jul 6. pii: EIJ-D-21-00230. doi: 10.4244/EIJ-D-21-00230.
    PubMed    
    Abstract available

  63. IVARSSON B, Johansson A, Kjellstrom B
    The Odyssey from Symptom to Diagnosis of Pulmonary Hypertension from the Patients and Spouses Perspective.
    J Prim Care Community Health. 2021;12:21501327211029241.
    PubMed    
    Abstract available

  64. HENDRIKS PM, van Thor MCJ, Wapenaar M, Chandoesing P, et al
    The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Respir Med. 2021;186:106525.
    PubMed    
    Abstract available

  65. TRIANTAFYLLIDI H, Birmpa D, Benas D, Ikonomidis I, et al
    May We Use Non-Invasive Indices of Aortic Stiffness and Endothelial Glycocalyx as Biomarkers for Idiopathic Pulmonary Artery Hypertension Follow-Up?
    Medicina (Kaunas). 2021;57.
    PubMed    
    Abstract available

  66. WU Y, Zhan S, Xu Y, Gao X, et al
    RNA modifications in cardiovascular diseases, the potential therapeutic targets.
    Life Sci. 2021;278:119565.
    PubMed    
    Abstract available

  67. BOFARID S, Hosman AE, Mager JJ, Snijder RJ, et al
    Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  68. NAKAYA T, Tsujino I, Nakamura J, Chiba Y, et al
    Right ventricular pressure-volume loop produced with simultaneous application of three-dimensional echocardiography and high-fidelity micromanometry in a patient with pulmonary arterial hypertension.
    Echocardiography. 2021;38:805-807.
    PubMed    
    Abstract available

  69. XU X, Feng H, Dai C, Lu W, et al
    Therapeutic efficacy of the novel selective RNA polymerase I inhibitor CX-5461 on pulmonary arterial hypertension and associated vascular remodelling.
    Br J Pharmacol. 2021;178:1605-1619.
    PubMed    
    Abstract available

  70. BIDVIENE J, Muraru D, Maffessanti F, Ereminiene E, et al
    Regional shape, global function and mechanics in right ventricular volume and pressure overload conditions: a three-dimensional echocardiography study.
    Int J Cardiovasc Imaging. 2021;37:1289-1299.
    PubMed    
    Abstract available

  71. ZHANG H, Hao LZ, Pan JA, Gao Q, et al
    Microfluidic fabrication of inhalable large porous microspheres loaded with H2S-releasing aspirin derivative for pulmonary arterial hypertension therapy.
    J Control Release. 2021;329:286-298.
    PubMed    
    Abstract available

  72. CARPIO AM, Goertz A, Kelly C, Willes L, et al
    Unrecognized pulmonary arterial hypertension in hospitalized patients.
    Int J Cardiovasc Imaging. 2021;37:1237-1243.
    PubMed    
    Abstract available

  73. CHEN Q, Xiao J, Duan Z, Shi L, et al
    Novel A4GALT gene variation with rare p phenotype in a compound heterozygous Chinese individual.
    Transfusion. 2021;61:E5-E6.
    PubMed    


  74. AFRASIABIRAD A, Samadi M, Vatani P, Faridvand Y, et al
    Valve patch technique for repair of ventricular septal defect: long-term results.
    Asian Cardiovasc Thorac Ann. 2021;29:161-164.
    PubMed    
    Abstract available

  75. LEE HJ, Kwon YB, Kang JH, Oh DW, et al
    Inhaled bosentan microparticles for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
    J Control Release. 2021;329:468-481.
    PubMed    
    Abstract available

  76. PANAGIOTIDOU E, Boutou A, Kalamara E, Sourla E, et al
    Diagnosis and management of combined post- and precapillary pulmonary hypertension in a patient with multiple comorbidities.
    Adv Respir Med. 2021 Jul 16. pii: VM/OJS/J/69425. doi: 10.5603/ARM.a2021.0047.
    PubMed    
    Abstract available

  77. RAO S, Khan A, Sampat P, Sandhu M, et al
    An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
    J Investig Med High Impact Case Rep. 2021;9:23247096211032821.
    PubMed    
    Abstract available

  78. GERGES C, Friewald R, Gerges M, Shafran I, et al
    Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension.
    Circ Cardiovasc Interv. 2021 Jul 16:CIRCINTERVENTIONS120010243.
    PubMed    
    Abstract available

  79. ARNON-SHELEG E
    [THE ROLE OF NUCLEAR MEDICINE IN THE WORKUP OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN A PATIENT SUFFERING FROM SYNCOPE AND SHORTNESS OF BREATH].
    Harefuah. 2021;160:415-418.
    PubMed    
    Abstract available

  80. TANAKA TD, Ishizawar DC, Saito T, Yoshii A, et al
    Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report.
    Pulm Circ. 2021;11:20458940211027791.
    PubMed    
    Abstract available

  81. ZHANG H, Sun T, Yang J, Sun Y, et al
    Lipocalin 2: could it be a new biomarker in pediatric pulmonary hypertension associated with congenital heart disease?
    Rev Cardiovasc Med. 2021;22:531-536.
    PubMed    
    Abstract available

  82. LEE ML, Chang MC, Wang YM
    Ischemia and No Obstructive Coronary Artery Disease and Pulmonary Hypertension in a 16-Year-Old Girl with Unquenched Hyperthyroidism of Graves' Disease.
    Acta Cardiol Sin. 2021;37:442-448.
    PubMed    


  83. GENECAND L, Adler D, Beghetti M, Lador F, et al
    Cardiac Output Determination in Precapillary Pulmonary Hypertension: A Systematic Review.
    Respiration. 2021 Jul 13:1-8. doi: 10.1159/000517084.
    PubMed    
    Abstract available

  84. WALTER R, Hunter K, Stenmark K, Kheyfets V, et al
    Hemodynamically Unloading the Distal Pulmonary Circulation in Pulmonary Hypertension - A Modeling Study.
    J Biomech Eng. 2021 Jul 12. pii: 1114506. doi: 10.1115/1.4051719.
    PubMed    
    Abstract available

  85. SAKURAI S, Ukyo Y
    Results of Macitentan in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension- A Prospective, Multicenter, Open-Label, Single-Arm, Phase 3 Study.
    Circ Rep. 2021;3:405-413.
    PubMed    
    Abstract available

  86. CHEN Y, Zhang D, Li Y, Yan A, et al
    Risk Factors and Outcomes of Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia: A Meta-Analysis.
    Front Pediatr. 2021;9:695610.
    PubMed    
    Abstract available

  87. TRAVERS A, Farber HW, Sarnak MJ
    Pulmonary Hypertension in Chronic Kidney Disease.
    Cardiol Clin. 2021;39:427-434.
    PubMed    
    Abstract available

  88. SANNA GD, Parodi G
    Accuracy of echocardiography in pulmonary hypertension: thinking outside of the box beyond the Achilles' heel of right atrial pressure estimation.
    Int J Cardiovasc Imaging. 2021 Jul 10. pii: 10.1007/s10554-021-02345.
    PubMed    


  89. ELASSAL A, Steppan J, Charania S, Santhanam L, et al
    Pressure-based estimation of right ventricular ejection fraction: Validation as a clinically relevant target for drug development in a rodent model of pulmonary hypertension.
    J Pharmacol Toxicol Methods. 2021;112:107102.
    PubMed    
    Abstract available

  90. HUANG N, Zhu TT, Liu T, Ge XY, et al
    Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.
    Eur J Pharmacol. 2021;908:174307.
    PubMed    
    Abstract available

  91. COBRA SB, Rodrigues MP, de Melo FX, Ferreira NMC, et al
    Right ventricular contractility decreases during exercise in patients with non-advanced idiopathic pulmonary fibrosis.
    Medicine (Baltimore). 2021;100:e25915.
    PubMed    
    Abstract available

  92. BARRADAS-PIRES A, Segura de la Cal T, Constantine A, Dimopoulos K, et al
    Systemic microangiopathy in Eisenmenger syndrome - The missing link?
    Int J Cardiol. 2021;337:62-63.
    PubMed    


  93. PELENGHI S, Primiceri C, Belliato M, Ghio S, et al
    Is it time for a paradigm shift: Should double-lung transplant be considered the treatment of choice for idiopathic pulmonary arterial hypertension and giant pulmonary aneurysm?
    J Card Surg. 2021;36:2996-2999.
    PubMed    
    Abstract available

  94. CERVANTES-SALAZAR JL, Garcia-Montes JA, Peralta-Santos H, Ortega-Zhindon DB, et al
    Rehabilitation of pulmonary arteries: Hybrid treatment in the unilateral absence of the pulmonary artery.
    J Card Surg. 2021;36:2970-2973.
    PubMed    
    Abstract available

  95. GU M, Donato M, Guo M, Wary N, et al
    iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension.
    Sci Transl Med. 2021;13.
    PubMed    
    Abstract available

  96. LEE SE, Hyun Kong J, Kim SH, Jang EJ, et al
    Change of right ventricular systolic pressure can indicate dasatinib-induced pulmonary arterial hypertension in chronic myeloid leukemia.
    Cancer Med. 2021;10:1515-1524.
    PubMed    
    Abstract available

  97. HUNG CC, Cheng CC, Huang WC
    2018 TSOC guideline focused updated on diagnosis and treatment of pulmonary arterial hypertension.
    J Formos Med Assoc. 2021;120:1541-1542.
    PubMed    


  98. ROY B, Vacas S, Ehlert L, McCloy K, et al
    Brain Structural Changes in Patients with Pulmonary Arterial Hypertension.
    J Neuroimaging. 2021;31:524-531.
    PubMed    
    Abstract available

  99. BUTROUS G
    Pulmonary Vascular Diseases Associated with Infectious Disease-Schistosomiasis and Human Immunodeficiency Viruses.
    Clin Chest Med. 2021;42:71-80.
    PubMed    
    Abstract available

  100. RAMIREZ RL 3RD, Pienkos SM, de Jesus Perez V, Zamanian RT, et al
    Pulmonary Arterial Hypertension Secondary to Drugs and Toxins.
    Clin Chest Med. 2021;42:19-38.
    PubMed    
    Abstract available

  101. KEARNEY K, Kotlyar E, Lau EMT
    Pulmonary Vascular Disease as a Systemic and Multisystem Disease.
    Clin Chest Med. 2021;42:167-177.
    PubMed    
    Abstract available

  102. PIECHURA LM, Rinewalt DE, Mallidi HR
    Advanced Surgical and Percutaneous Approaches to Pulmonary Vascular Disease.
    Clin Chest Med. 2021;42:143-154.
    PubMed    
    Abstract available

  103. STEPPAN J, Heerdt PM
    Preoperative Assessment and Perioperative Management of the Patient with Pulmonary Vascular Disease.
    Clin Chest Med. 2021;42:133-141.
    PubMed    
    Abstract available

  104. AHARI J, Bhatnagar A, Johnson A, Gomberg-Maitland M, et al
    Contemporary Pharmacotherapeutic Approach in Pulmonary Arterial Hypertension.
    Clin Chest Med. 2021;42:125-131.
    PubMed    
    Abstract available

  105. JIN H, Jiao Y, Guo L, Ma Y, et al
    Astragaloside IV blocks monocrotalineinduced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling.
    Int J Mol Med. 2021;47:595-606.
    PubMed    
    Abstract available

  106. KARTHIKA CL, Ahalya S, Radhakrishnan N, Kartha CC, et al
    Hemodynamics mediated epigenetic regulators in the pathogenesis of vascular diseases.
    Mol Cell Biochem. 2021;476:125-143.
    PubMed    
    Abstract available

  107. SUN X, Wang C, Liu Y, Chen X, et al
    Clinical impact of new diagnostic criteria for postcapillary pulmonary hypertension.
    Int J Cardiol. 2021 Jul 19. pii: S0167-5273(21)01183.
    PubMed    


  108. HASSAN HJ, Housten T, Balasubramanian A, Simpson CE, et al
    A novel approach to perioperative risk assessment for patients with pulmonary hypertension.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  109. KERANOV S, Dorr O, Jafari L, Liebetrau C, et al
    Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension.
    Biomark Med. 2021 Jul 22. doi: 10.2217/bmm-2021-0009.
    PubMed    
    Abstract available

  110. EGBE AC, Miranda WR, Connolly HM, Borlaug BA, et al
    Coarctation of Aorta is Associated with Left Ventricular Stiffness, Left Atrial Dysfunction and Pulmonary Hypertension.
    Am Heart J. 2021 Jul 18. pii: S0002-8703(21)00184.
    PubMed    
    Abstract available

  111. OTA-ARAKAKI JS, Campos FTAF, Souza R
    World Pulmonary Hypertension Day: reflections and planning.
    J Bras Pneumol. 2021;47:e20210251.
    PubMed    


  112. NIJIATI Y, Maimaitiyiming D, Yang T, Li H, et al
    Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora.
    Eur Rev Med Pharmacol Sci. 2021;25:4540-4553.
    PubMed    
    Abstract available

  113. ANTHI A, Tsiapras D, Karyofyllis P, Voudris V, et al
    The wide spectrum of beta-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy.
    Pulm Circ. 2021;11:20458940211030490.
    PubMed    
    Abstract available

  114. TANIGUCHI H, Takashima T, Tu L, Thuillet R, et al
    Pulmonary hypertension associated with neurofibromatosis type 2.
    Pulm Circ. 2021;11:20458940211029550.
    PubMed    
    Abstract available

  115. BAJOLLE F, Malekzadeh-Milani S, Levy M, Bonnet D, et al
    Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and BMPR-2 mutation.
    Pulm Circ. 2021;11:20458940211027433.
    PubMed    
    Abstract available

  116. TILEA I, Petra DN, Serban RC, Gabor MR, et al
    Short-Term Impact of Iron Deficiency in Different Subsets of Patients with Precapillary Pulmonary Hypertension from an Eastern European Pulmonary Hypertension Referral Center.
    Int J Gen Med. 2021;14:3355-3366.
    PubMed    
    Abstract available

  117. CADDIGAN S, Granlund B, Sakarin S, Rungsipipat A, et al
    Histopathological changes of pulmonary vascular remodeling in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
    J Vet Cardiol. 2021;36:141-152.
    PubMed    
    Abstract available

  118. MUSTAFAOGLU R, Demir R, Aslan GK, Sinan UY, et al
    Translation, cross-cultural adaptation, reliability, and validity of the Turkish version of the Duke Activity Status Index in patients with pulmonary hypertension.
    Pulmonology. 2021 Jul 16. pii: S2531-0437(21)00130.
    PubMed    


  119. LI Y, Guo D, Gong J, Wang J, et al
    Right Ventricular Function and Its Coupling With Pulmonary Circulation in Precapillary Pulmonary Hypertension: A Three-Dimensional Echocardiographic Study.
    Front Cardiovasc Med. 2021;8:690606.
    PubMed    
    Abstract available

  120. SUN Y, Wang L, Meng X, Gong S, et al
    Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension.
    J Thorac Dis. 2021;13:3478-3488.
    PubMed    
    Abstract available

  121. WANG L, Shen L, Zhao YL, Pudasaini B, et al
    Survival in severe pulmonary hypertension due to chronic lung disease: influence of in-hospital platelet distribution width.
    Pulm Circ. 2021;11:20458940211026484.
    PubMed    
    Abstract available

  122. HARROD KK, Rogers JL, Feinstein JA, Marsden AL, et al
    Predictive Modeling of Secondary Pulmonary Hypertension in Left Ventricular Diastolic Dysfunction.
    Front Physiol. 2021;12:666915.
    PubMed    
    Abstract available

  123. MAIER A, Liao SL, Lescure T, Robson PM, et al
    Pulmonary Artery (18)F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis.
    JACC Cardiovasc Imaging. 2021 Jul 8. pii: S1936-878X(21)00488.
    PubMed    
    Abstract available

  124. SHOWALTER K, Pinheiro LC, Jannat-Khah D, Sobol I, et al
    Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry.
    Rheumatology (Oxford). 2021 Jul 17. pii: 6323372.
    PubMed    
    Abstract available

  125. BARZIN A
    Heart Failure: Right-Sided Heart Failure.
    FP Essent. 2021;506:27-30.
    PubMed    
    Abstract available

  126. FORTAS F, Di Nardo M, Yousef N, Humbert M, et al
    Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm.
    Eur J Pediatr. 2021;180:2379-2387.
    PubMed    
    Abstract available

  127. KRASINKIEWICZ JM, Lahm T
    Riding the Ferrous Wheel of Iron Supplementation in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2021;18:946-948.
    PubMed    


  128. DONG H, Li X, Cai M, Zhang C, et al
    Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension.
    Aging (Albany NY). 2021;13:14234-14257.
    PubMed    
    Abstract available

  129. BARRADAS-PIRES A, Constantine A, Dimopoulos K
    Preventing disease progression in Eisenmenger syndrome.
    Expert Rev Cardiovasc Ther. 2021;19:501-518.
    PubMed    
    Abstract available

  130. MENG L, Yuan W, Chi H, Han R, et al
    Genetic deletion of CMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterial hypertension.
    FASEB J. 2021;35:e21421.
    PubMed    
    Abstract available

  131. VIRAY MC, Bonno EL, Houston BA, Tedford RJ, et al
    Response by Viray et al to Letter Regarding Article, "Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study".
    Circ Heart Fail. 2021;14:e008304.
    PubMed    


  132. HARDIN EA, Araj FG
    Letter by Hardin and Araj Regarding Article, "Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study".
    Circ Heart Fail. 2021;14:e008158.
    PubMed    


  133. ZHOU XL, Huang FJ, Li Y, Huang H, et al
    SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.
    Aging (Albany NY). 2021;13:7538-7548.
    PubMed    
    Abstract available

  134. HEKMATI S
    Reply to letter to editor: Association between pulmonary arterial obstruction index and right lateral ventricular wall thickness with in-hospital mortality in patients with acute pulmonary embolism.
    Emerg Radiol. 2021;28:865.
    PubMed    


  135. SHARMA S, Hofbauer TM, Ondracek AS, Chausheva S, et al
    Neutrophil extracellular traps promote fibrous vascular occlusions in chronic thrombosis.
    Blood. 2021;137:1104-1116.
    PubMed    
    Abstract available

  136. RAWAL H, Suman A, Bhoite RR, Kanwal A, et al
    Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer?
    Curr Probl Cardiol. 2021;46:100738.
    PubMed    
    Abstract available

  137. NAVARRO-VERGARA DI, Roldan-Valadez E, Cueto-Robledo G, Jurado-Hernandez MY, et al
    Portopulmonary Hypertension: Prevalence, Clinical and Hemodynamic Features.
    Curr Probl Cardiol. 2021;46:100747.
    PubMed    
    Abstract available

  138. BADAGLIACCA R, Pezzuto B, Papa S, Poscia R, et al
    Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2021;14:162-172.
    PubMed    
    Abstract available

  139. KAYMAK E, Akin AT, Tufan E, Basaran KE, et al
    The effect of chloroquine on the TRPC1, TRPC6, and CaSR in the pulmonary artery smooth muscle cells in hypoxia-induced experimental pulmonary artery hypertension.
    J Biochem Mol Toxicol. 2021;35:e22636.
    PubMed    
    Abstract available

  140. GUO X, Lai J, Wang H, Tian Z, et al
    Predictive value of non-invasive right ventricle to pulmonary circulation coupling in systemic lupus erythematosus patients with pulmonary arterial hypertension.
    Eur Heart J Cardiovasc Imaging. 2021;22:111-118.
    PubMed    
    Abstract available

  141. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    Comparison of In-Hospital Outcomes of Transcatheter Mitral Valve Repair in Patients With vs Without Pulmonary Hypertension (From the National Inpatient Sample).
    Am J Cardiol. 2021 Jun 28. pii: S0002-9149(21)00496.
    PubMed    
    Abstract available

  142. VU LD, Saravia J, Jaligama S, Baboeram Panday RV, et al
    Deficiency of ST2 signaling ameliorates RSV-associated pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2021 Jun 25. doi: 10.1152/ajpheart.00018.2021.
    PubMed    
    Abstract available

  143. CHARNIN JE
    Pulmonary Hypertension: Controversial and Emerging Topics.
    Anesth Analg. 2021;133:e18-e19.
    PubMed    


  144. MONTANE BE, Fiore AM, Reznicek EC, Jain V, et al
    Optimal Tricuspid Regurgitation Velocity to Screen for Pulmonary Hypertension in Tertiary Referral Centers.
    Chest. 2021 Jul 1. pii: S0012-3692(21)01276-9. doi: 10.1016/j.chest.2021.
    PubMed    
    Abstract available

  145. QI H, Liu H, Pullamsetti SS, Gunther S, et al
    Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells is Required to Prevent Pulmonary Hypertension and COPD.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.051680.
    PubMed    
    Abstract available

  146. MAEDER MT, Weber L, Weilenmann D, Chronis J, et al
    Impact of the new pulmonary hypertension definition on long-term mortality in patients with severe aortic stenosis undergoing valve replacement.
    Clin Cardiol. 2021 Jul 4. doi: 10.1002/clc.23685.
    PubMed    
    Abstract available

  147. KEEN JL, Thenappan T
    Shifting gears: the search for group 3 pulmonary hypertension treatment.
    Curr Opin Pulm Med. 2021 Jun 25. pii: 00063198-900000000-98952.
    PubMed    
    Abstract available

  148. PROHASKA CC, Machado RF
    The different facets of sickle cell disease-related pulmonary hypertension.
    Curr Opin Pulm Med. 2021 Jul 1. pii: 00063198-900000000-98948.
    PubMed    
    Abstract available

  149. SHIMOKAWAHARA H, Ogawa A, Matsubara H
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: advances in patient and lesion selection.
    Curr Opin Pulm Med. 2021 Jul 1. pii: 00063198-900000000-98947.
    PubMed    
    Abstract available

  150. NAZARIO RA, Goldraich LA, Hastenteufel LCT, Santos ABS, et al
    Donor-recipient predicted heart mass ratio and right ventricular-pulmonary arterial coupling in heart transplant.
    Eur J Cardiothorac Surg. 2020 Nov 30. pii: 6227020. doi: 10.1093.
    PubMed    
    Abstract available

  151. ULRICH S, Grunig E
    The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment.
    Eur Respir J. 2021;57.
    PubMed    


  152. BOGAARD HJ, Sitbon O
    Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated.
    Eur Respir J. 2021;57.
    PubMed    


  153. AMSALLEM M, Sweatt AJ, Arthur Ataam J, Guihaire J, et al
    Targeted proteomics of right heart adaptation to pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed    
    Abstract available

  154. BORGESE M, Badesch D, Bull T, Chakinala M, et al
    EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR.
    Eur Respir J. 2021;57.
    PubMed    
    Abstract available

  155. MACIAS D, Moore S, Crosby A, Southwood M, et al
    Targeting HIF2alpha-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed    
    Abstract available

  156. HAARMAN MG, Levy M, Roofthooft MTR, Douwes JM, et al
    Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed    
    Abstract available

  157. LEWIS RA, Armstrong I, Bergbaum C, Brewis MJ, et al
    EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.
    Eur Respir J. 2021;57.
    PubMed    
    Abstract available

  158. LAUNAY D, Sanges S, Sobanski V
    Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed    


  159. PEREZ-OLIVARES C, Segura de la Cal T, Flox-Camacho A, Nuche J, et al
    The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease.
    Eur Respir J. 2021;57.
    PubMed    


  160. AWADA C, Grobs Y, Wu WH, Habbout K, et al
    R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models.
    Eur Respir J. 2021;57.
    PubMed    


  161. RAHAGHI FN, Hilton JF, Correa RA, Loureiro C, et al
    Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed    


  162. BAUER Y, de Bernard S, Hickey P, Ballard K, et al
    Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort.
    Eur Respir J. 2021;57.
    PubMed    
    Abstract available

  163. LIM K, Yang JH, Miranda WR, Chang SA, et al
    Clinical significance of pulmonary hypertension in patients with constrictive pericarditis.
    Heart. 2021 Jul 20. pii: heartjnl-2021-319149. doi: 10.1136/heartjnl-2021-319149
    PubMed    
    Abstract available

  164. DE JESUS SILVA F, Drummond FR, Fidelis MR, Freitas MO, et al
    Continuous aerobic exercise prevents detrimental remodeling and right heart myocyte contraction and calcium cycling dysfunction in pulmonary artery hypertension.
    J Cardiovasc Pharmacol. 2020 Oct 9. doi: 10.1097/FJC.0000000000000928.
    PubMed    
    Abstract available

  165. DAURIAT G, Reynaud-Gaubert M, Cottin V, Lamia B, et al
    Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.
    J Heart Lung Transplant. 2021 May 11. pii: S1053-2498(21)02307.
    PubMed    
    Abstract available

  166. WONG MKH, Hsin MK
    Commentary: The perfidious left ventricle in pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2021 Jun 24. pii: S0022-5223(21)00890.
    PubMed    


  167. KLAPPER JA
    Commentary: Respect idiopathic pulmonary hypertension...or urine trouble.
    J Thorac Cardiovasc Surg. 2021 Jun 23. pii: S0022-5223(21)00896.
    PubMed    


  168. FECZKO AF, Raja S
    Commentary: The pressure to treat pulmonary artery hypertension.
    J Thorac Cardiovasc Surg. 2021;161:e435-e436.
    PubMed    


  169. DATE H
    Commentary: A new treatment strategy for pulmonary arterial hypertension.
    J Thorac Cardiovasc Surg. 2021;161:e436-e437.
    PubMed    


  170. ISHIBASHI N, Jonas RA
    Commentary: Nitric oxide: An important contributor to neuroprotection during pediatric cardiac surgery.
    J Thorac Cardiovasc Surg. 2020 Jan 7. pii: S0022-5223(20)30032.
    PubMed    


  171. YANG P, Bocobo GA, Yu PB
    Sotatercept for Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;385:92-93.
    PubMed    


  172. WU WH, Bonnet S, Shimauchi T, Toro V, et al
    Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.
    Thorax. 2021 Jul 5. pii: thoraxjnl-2021-217377.
    PubMed    
    Abstract available

  173. ABLONCZY L, Ferenci T, Somoskovi O, Osvath R, et al
    Prognostic Value of Early Risk Stratification in Pediatric Pulmonary Arterial Hypertension.
    Transplant Proc. 2021;53:1439-1442.
    PubMed    
    Abstract available

  174. FUJII S, Nagayoshi S, Ogawa K, Muto M, et al
    A pilot cohort study assessing the feasibility of complete revascularization with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    PLoS One. 2021;16:e0254770.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;